Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma

Chemotherapy is among the limited choices approved for the treatment of hepatocellular carcinoma (HCC) at intermediate and advanced stages. Preferential and prolonged drug exposure in diseased sites is required to maximize the therapeutic index of the drug. Here, we report an injectable supramolecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiyue, Liu, Xiaoyu, Zhang, Pengcheng, Liu, Yiran, Ran, Wei, Cai, Ying, Wang, Junyang, Zhai, Yihui, Wang, Guanru, Ding, Yaping, Li, Yaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804453/
https://www.ncbi.nlm.nih.gov/pubmed/31649853
http://dx.doi.org/10.1016/j.apsb.2019.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804453/
https://www.ncbi.nlm.nih.gov/pubmed/31649853
http://dx.doi.org/10.1016/j.apsb.2019.06.001

Ejemplares similares